WHC is still in active development. Read this to understand our approach.
depiction of LELBFTMXCIIKKX-UHFFFAOYSA-N.svg
isomerdesign

Methyl (16E)-9-metho...

Verificar en isomerdesign

isomerdesign

Methyl (16E)-9-metho...

Verificar en isomerdesign

isomerdesign

Methyl (16E)-9-metho...

Verificar en isomerdesign

pubchem

Mitragynine

Verificar en pubchem

wiki

Mitragynine

Verificar en wiki

wiki

Speciociliatine

Verificar en wiki

Data

InChI: InChI=1S/C23H30N2O4/c1-5-14-12-25-10-9-15-21-18(7-6-8-20(21)28-3)24-22(15)19(25)11-16(14)17(13-27-2)23(26)29-4/h6-8,13-14,16,19,24H,5,9-12H2,1-4H3

Sinónimos: Methyl (3β,16E,20β)-9-methoxy-16-(methoxymethylidene)corynan-17-oate,Methyl (2E)-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate,methyl (2E)-2-[(2S,4S,5S)-5-ethyl-12-methoxy-7,17-diazatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1(10),11,13,15-tetraen-4-yl]-3-methoxyprop-2-enoate,Mitragynine - 95%,MITRAGYNINE PICRATE,9-Methoxycorynantheidine,Mitragynin,Methyl (16E)-9-methoxy-16-(methoxymethylidene)-3β,20β-corynan-17-oate,Methyl (16E,20β)-9-methoxy-16-(methoxymethylidene)corynan-17-oate,Methyl (2E)-2-[(2S,3S,12bR)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate,Methyl (2E)-2-(3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyprop-2-enoate,Skf 12711,MITRAGYNINE [WHO-DD],SK&F 12711,CHEMBL299031,6202-22-8,BM164595,Mitragynine [MI],BDBM50474152,Mitragynine solution, 100 mug/mL in methanol, ampule of 1 mL, certified reference material,Q414299,methyl(e)-2-[(2s,3s,12bs)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate,Methyl (16E)-9-methoxy-16-(methoxymethylidene)corynan-17-oate,CHEBI:6956,SCHEMBL875800,Methyl (16E)-9-methoxy-16-(methoxymethylidene)-20β-corynan-17-oate,(.ALPHA.E,2S,3S,12.BETA.S)-3-ETHYL-1,2,3,4,6,7,12,12B-OCTAHYDRO-8-METHOXY-.ALPHA.-(METHOXYMETHYLENE)-INDOLO(2,3-A)QUINOLIZINE-2-ACETIC ACID METHYL ESTER,HSDB 7901,4098-40-2,EP479K822J,(-)-Mitragynine,SCHEMBL875799,UNII-EP479K822J,ZINC13473305,C09226,INDOLO(2,3-A)QUINOLIZINE-2-ACETIC ACID, 3-ETHYL-1,2,3,4,6,7,12,12B-OCTAHYDRO-8-METHOXY-.ALPHA.-(METHOXYMETHYLENE)-, METHYL ESTER, (.ALPHA.E,2S,3S,12BS)-,DTXSID701032140,MITRAGYNINE,16,17-Didehydro-9,17-dimethoxy-17,18-seco-20-alpha-yohimban-16-carboxylic acid methyl ester,(E)-Methyl 2-((2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate

Estimated data

Solubilidad: -3.849 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 89.4% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.